Semaglutide in Ozempic linked to better mental health
Semaglutide, the active substance in the diabetes and obesity drug Ozempic, may be linked to significantly reduced sick leave and a reduced need for mental health care.
SwedenSemaglutide, the active substance in the diabetes and obesity drug Ozempic, may be linked to significantly reduced sick leave and a reduced need for mental health care.
SwedenYou're up to date in Institutionen för klinisk neurovetenskap
That's every story in Institutionen för klinisk neurovetenskap for now.